ask="0.68"
ask_size="6300"
average_daily_volume="561250"
bid="0.49"
bid_size="1000"
book_value="0.81"
change="-0.02"
change_from_200_day_moving_average="-0.02"
change_from_50_day_moving_average="-0.01"
change_from_52_week_high="-0.88"
change_From_52_week_low="0.21"
change_in_percent="-3.57%"
close="0.54"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.54"
ebitda="-17.93M"
eps_estimate_current_year="-0.78"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.57"
ex_dividend_date="N/A"
float_shares="29627000"
high="0.56"
high_52_weeks="1.42"
last_trade_date="2/1/2017"
last_trade_price="0.54"
last_trade_size="224"
last_trade_time="4:00pm"
low="0.52"
low_52_weeks="0.33"
market_capitalization="16.21M"
moving_average_200_day="0.56"
moving_average_50_day="0.55"
name="OncoGenex Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="0.90"
open="0.54"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-3.09%"
percent_change_from_50_day_moving_average="-1.38%"
percent_change_from_52_week_high="-61.97%"
percent_change_from_52_week_low="+63.14%"
previous_close="0.56"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.69"
price_per_sales="1.52"
revenue="11.09M"
shares_outstanding="30020000"
short_ratio="0.83"
stock_exchange="NCM"
symbol="OGXI"
volume="144365"
weeks_range_52="0.33 - 1.42"
